View and download slide summaries of the latest original articles focusing on cytokine signalling therapies within rheumatoid arthritis. All materials produced by the CSF team are subsequently reviewed and approved by individual Steering Committee members.
体軸型脊椎関節炎におけるセクキヌマブの実臨床上継続率と有効率: CanSpA リサーチネットワークからの解析
J Rheumatol. 2023 jrheum doi: 10.3899/jrheum.220824
The results of this real-world study of Canadian axSpA patients, the first of its kind, support the effectiveness of secukinumab for treatment of axSpA. This study aimed to use the CanSpA Research Network to describe real-world retention and effectiveness of secukinumab in the Canadian axSpA population.